JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hashimoto, K.
Right arrow Articles by Takeuchi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hashimoto, K.
Right arrow Articles by Takeuchi, S.
Related Collections
Right arrow Cardiac - physiology
Right arrow Extracorporeal circulation

J Thorac Cardiovasc Surg 2001;121:1179-1186
© 2001 The American Association for Thoracic Surgery


Cardiopulmonary Support and Physiology

Superior hepatic mitochondrial oxidation-reduction state in normothermic cardiopulmonary bypass

Kazuhiro Hashimoto, MD, Tatsuumi Sasaki, MD, Takashi Hachiya, MD, Katsuhisa Onoguchi, MD, Hiromitsu Takakura, MD, Motohiro Oshiumi, MD, Shigeyuki Takeuchi, MD

From the Department of Cardiovascular Surgery, Saitama Cardiovascular and Respiratory Center, Saitama-ken, Japan.

Supported by the institutional research fund of Saitama Cardiovascular and Respiratory Center.

Received for publication May 10, 2000 Revisions requested Sept 5, 2000; revisions received Sept 18, 2000. Accepted for publication Dec 1, 2000. Address for reprints: Kazuhiro Hashimoto, MD, Saitama Cardiovascular and Respiratory Center, Department of Cardiovascular Surgery, 1696 Itai, Konan-machi, Osato-gun, Saitama-ken, 360-0105, Japan (E-mail: drs-hashimoto @mti.biglobe.ne.jp).

Objective: This study is the first comparative investigation of hepatic blood flow and oxygen metabolism during normothermic and hypothermic cardiopulmonary bypass.
Methods: Twenty-four patients undergoing coronary bypass operations were randomly divided into 2 groups according to their perfusion temperatures, either normothermia (36°C) or hypothermia (30°C). The clearance of indocyanine green was measured at 3 points. Arterial and hepatic venous ketone body ratios (an index of mitochondrial redox potential) and hepatic venous saturation were measured.
Results: Hepatic blood flow in both groups was identical before, during, and after cardiopulmonary bypass (normothermia, 499 ± 111, 479 ± 139, and 563 ± 182 mL/min, respectively; hypothermia, 476 ± 156, 491 ± 147, and 560 ± 202 mL/min, respectively). The hepatic venous saturation levels were significantly lower during cardiopulmonary bypass in the normothermic group (normothermia, 41% ± 13%; hypothermia, 61% ± 18%; P < .01), indicating a higher level of oxygen extraction use. The arterial ketone body ratio in the hypothermic group decreased severely after the onset of cardiopulmonary bypass (P < .01) and did not return to its subnormal value (>0.7) until the second postoperative day. However, the reduction in arterial ketone body ratio was less severe in the normothermic group. The difference in hepatic venous ketone body ratios was more obvious, and the hepatic venous ketone body ratios in the normothermic group were statistically superior to those of the hypothermic group throughout the course (P < .05-.01).
Conclusions: Normothermic cardiopulmonary bypass provides adequate liver perfusion and results in a better hepatic mitochondrial redox potential than hypothermic cardiopulmonary bypass. Because arterial ketone body ratios reflect hepatic energy potential, normothermia was considered to be physiologically more advantageous for hepatic function.




This article has been cited by other articles:


Home page
Card Surg AdultHome page
H. Laks, D. Marelli, M. Plunkett, and J. Myers
Adult Congenital Heart Disease
Card. Surg. Adult, January 1, 2008; 3(2008): 1431 - 1464.
[Full Text]


Home page
Canadian J. AnesthesiaHome page
E. Farag, M. Argalious, S. Narouze, G. E. DeBoer, and J. Tome
The anesthetic management of ventricular septal defect (VSD) repair in a child with mitochondrial cytopathy : [La demarche anesthesique adoptee pendant la reparation d'une communication interventriculaire (CIV) chez une enfant presentant une cytopathie mitochondriale]
Can J Anesth, November 1, 2002; 49(9): 958 - 962.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The American Association for Thoracic Surgery.